LAS VEGAS, June 21, 2011 /PRNewswire/ -- Gamma Pharmaceuticals, Inc. (NASDAQ: GMPM.PK), (“Gamma” or the “Company”,) a marketing and product formulation company selling its own branded products through wholesalers and direct to retailers, both in the US and internationally, announced a special meeting for its shareholders.
TO OUR STOCKHOLDERS:
Over the past few months, in particular, we have had numerous phone calls from stockholders stating their obvious concerns over the lack of ongoing communication regarding our Company’s progress and the overall performance of our Common Stock. These two factors have led many of those with whom we have spoken to express concern over the overall “health” of our company and its prospects in this difficult economic environment.
To that end, Gamma’s Board of Directors (the “Board”) have organized a Special Shareholders Meeting on July 9, 2011 commencing at 1:00pm at the Bellagio Resort, Las Vegas.
The purpose of the meeting is to provide a forum for Gamma’s current investors to discuss the direction of the Company in the months ahead and to review Gamma’s recent operating history, reflecting the Company’s effort to enhance investor communications. Each participant will require a ticket to gain entrance to the meeting and a dial-in number can be made available. Those wishing to attend or to participate by conference call may contact Gamma’s CFO, Joseph Cunningham at (651) 204-2048 or by email at jcunningham@gammapharma.com
The recent past has been challenging for Gamma, but the Company has begun to clear the road ahead of most obstacles and Board looks forward to an open and candid discussion on Gamma’s future. The Board is grateful to Gamma’s investors as the Company continues the journey upon which we embarked. The Board of Directors looks forward to having a good turnout on July 9th and we thank you in advance for your participation in this important meeting.
Best regards,
The Board of Directors, Gamma’s Pharmaceuticals, Inc.
SOURCE Gamma Pharmaceuticals, Inc.
